Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
outcome not independently re-confirmed in this session owner re-verify before quoting primary endpoint result
Which Option is Best for You
Description Cagrilintide is an investigational, long-acting synthetic peptide that acts as a dual amylin and calcitonin receptor agonist (DACRA), primarily under development for the treatment of obesity and type 2 diabetes
Am J Physiol-Regul Integr Comp Physiol
Discard the supernatant and resuspend the cells with stimulation buffer to a density of 0.6 million cells per mL, then add the cells to 384-well white plates (3,000 cells per well)
For instance, in an 8-week randomized controlled trial, tirzepatide treatment significantly reduced LDL cholesterol and C-reactive protein levels in patients with type 2 diabetes (Del et al., 2021)
US$ 24.43
US$ 20.78
US$ 26.69
US$ 21.60
US$ 22.46
US$ 25.90
